KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $141.98 $159.34 Thursday, 25th Apr 2024 ALNY stock ended at $143.71. This is 0.0626% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.67% from a day low at $141.98 to a day high of $145.77.
90 days $141.98 $184.29
52 weeks $141.98 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Jun 02, 2023 $190.88 $195.80 $188.81 $193.67 344 188
Jun 01, 2023 $185.81 $189.57 $184.07 $188.67 370 528
May 31, 2023 $186.36 $190.45 $183.88 $185.01 778 617
May 30, 2023 $186.71 $190.46 $186.20 $186.46 534 673
May 26, 2023 $188.33 $188.87 $185.13 $188.26 421 982
May 25, 2023 $185.93 $186.47 $183.00 $186.00 506 085
May 24, 2023 $191.12 $192.07 $185.63 $185.92 542 977
May 23, 2023 $193.06 $194.68 $190.68 $191.83 388 341
May 22, 2023 $191.38 $194.01 $189.30 $193.06 570 737
May 19, 2023 $191.48 $193.49 $189.58 $190.74 289 506
May 18, 2023 $191.10 $191.60 $186.26 $189.87 422 175
May 17, 2023 $191.28 $193.75 $187.17 $193.23 485 590
May 16, 2023 $202.70 $202.70 $189.21 $190.97 1 269 862
May 15, 2023 $205.66 $208.11 $204.36 $206.20 367 900
May 12, 2023 $206.11 $208.13 $204.46 $205.36 314 329
May 11, 2023 $211.16 $211.16 $204.15 $206.09 292 975
May 10, 2023 $209.39 $211.85 $208.40 $210.97 532 540
May 09, 2023 $207.81 $209.57 $204.43 $207.83 501 668
May 08, 2023 $211.34 $211.35 $205.66 $209.96 542 921
May 05, 2023 $209.01 $212.47 $207.17 $212.05 655 371
May 04, 2023 $201.72 $206.36 $200.04 $205.39 776 356
May 03, 2023 $200.70 $203.10 $198.21 $199.50 690 685
May 02, 2023 $201.37 $203.16 $198.42 $199.02 571 837
May 01, 2023 $198.87 $202.84 $196.73 $201.87 605 815
Apr 28, 2023 $195.13 $201.42 $193.96 $199.20 591 057
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT